FDA Adverse Event Malfunction Summary report: N

BD MINIDRAW¿ H&H CAPILLARY BLOOD COLLECTION TUBE

MDR report key: 20126923 · Received September 3, 2024

Report

Report Number
2618282-2024-00119
Event Type
Malfunction
Date Received
September 3, 2024
Date of Event
July 30, 2024
Report Date
May 23, 2025
Manufacturer
BD CARIBE LTD.
Product Code
GIM
UDI-DI
50382903666039
PMA / PMN Number
K230493
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS WERE UPDATED DUE TO ADDITIONAL INFORMATION: D9: DEVICE AVAILABLE FOR EVALUATION: YES. H.3 DEVICE EVAL BY MANUFACTURER? YES. D9: RETURNED TO MANUFACTURER ON 29-MAY-2024. INVESTIGATION SUMMARY : MATERIAL #: 366603; LOT/BATCH #: 4024091. BD RECEIVED TEN (10) CUSTOMER RETURNED SAMPLES FOR INVESTIGATION VIA RELATED COMPLAINT (B)(4). THE TEN SAMPLES WERE EVALUATED BY FUNCTIONAL TESTING FOR FACTORS RELATING TO THE INDICATED FAILURE MODE OF CLOTTING, AND NO ISSUES WERE OBSERVED. ADDITIONALLY, EIGHT (8) RETENTION SAMPLES FROM BD INVENTORY WERE EVALUATED BY FUNCTIONAL TESTING AND NO ISSUES WERE OBSERVED RELATING TO THE INDICATED FAILURE MODE CLOTTING. RETENTION SAMPLE TESTING REVEALED ALL SAMPLES MET THE PERFORMANCE SPECIFICATIONS OUTLINED IN THE STANDARD FOR SINGLE-USE CONTAINERS FOR HUMAN VENOUS BLOOD SPECIMEN COLLECTION (ISO6710). BD REQUESTED ADDITIONAL RETURN SAMPLES TO FURTHER EVALUATE THE PERFORMANCE OF THE DEVICE THROUGH AN INTERNAL BD CLINICAL STUDY. ONE-HUNDRED AND FIFTY (150) CUSTOMER SAMPLES WERE RECEIVED FOR FURTHER EVALUATION. OF THOSE, 67 CUSTOMER SAMPLES WERE EVALUATED VIA A CLINICAL STUDY EVALUATION. THE STUDY DID NOT OBSERVE ANY SAMPLE CLOTTING ISSUES WHEN SAMPLES WERE COLLECTED ACCORDING TO THE PRODUCT IFU. NO MACROSCOPIC CLOTS WERE OBSERVED FOR ANY SUCCESSFUL COLLECTIONS, EITHER IMMEDIATELY AFTER COLLECTION OR AFTER ~24 HOURS OF REFRIGERATION. THE STUDY REVEALED ALL SAMPLES TESTED MET SPECIFICATION, AND THE RATE OF OBSERVED CLOTS WAS (B)(4). BASED ON A REVIEW OF THE DEVICE HISTORY RECORD FOR THE INCIDENT LOT, ALL PRODUCT SPECIFICATIONS AND REQUIREMENTS FOR LOT RELEASE WERE MET. THERE WERE NO RELATED QUALITY ISSUES DURING MANUFACTURING OF THE PRODUCT. THIS COMPLAINT IS UNABLE TO BE CONFIRMED AND NO DEFINITIVE ROOT CAUSE WAS IDENTIFIED. COMPLAINTS RECEIVED FOR THIS DEVICE AND REPORTED CONDITION WILL CONTINUE TO BE TRACKED AND TRENDED. OUR BUSINESS TEAM REGULARLY REVIEWS THE COLLECTED DATA FOR IDENTIFICATION OF EMERGING TRENDS. BD QUALITY WILL CONTINUE TO MONITOR SAMPLE QUALITY COMPLAINTS.

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS HAVE BEEN UPDATED WITH CORRECTED INFORMATION (REMOVAL OF STATEMENT INDICATING THE SAMPLE WAS RECOLLECTED): B.5. "IT WAS REPORTED WHEN USING THE BD MINIDRAW¿ H&H CAPILLARY BLOOD COLLECTION TUBE THERE WAS CLOTTING IN ONE SAMPLE. THERE WERE NO OTHER HEALTH CONSEQUENCES OR IMPACTS REPORTED."

Additional Manufacturer Narrative · 0

A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 0

IT WAS REPORTED WHEN USING THE BD MINIDRAW¿ H&H CAPILLARY BLOOD COLLECTION TUBE THERE WAS CLOTTING IN ONE SAMPLE. THE SAMPLE WAS RECOLLECTED. THERE WERE NO OTHER HEALTH CONSEQUENCES OR IMPACTS REPORTED.

Description of Event or Problem · 0

IT WAS REPORTED WHEN USING THE BD MINIDRAW¿ H&H CAPILLARY BLOOD COLLECTION TUBE THERE WAS CLOTTING IN ONE SAMPLE. THERE WERE NO OTHER HEALTH CONSEQUENCES OR IMPACTS REPORTED.

Description of Event or Problem · 0

IT WAS REPORTED WHEN USING THE BD MINIDRAW¿ H&H CAPILLARY BLOOD COLLECTION TUBE THERE WAS CLOTTING IN ONE SAMPLE. THE SAMPLE WAS RECOLLECTED. THERE WERE NO OTHER HEALTH CONSEQUENCES OR IMPACTS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
735046 BD MINIDRAW¿ H&H CAPILLARY BLOOD COLLECTION TUBE CAPILLARY BLOOD COLLECTION TUBE IVD GIM BD CARIBE LTD. 4024091 50382903666039

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown